This compound is a protected phosphoramidite monomer specifically designed for use in oligonucleotide synthesis. Its structure incorporates a cytosine base with an acetyl protecting group on the exocyclic amine, a (S)-glycidyl nucleoside analog backbone, and standard phosphoramidite and dimethoxytrityl protecting groups.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1159174-80-7
(S)-GNA-C(Bz)-phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
Pharmaceutical intermediate for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
5'-DMT-PseudoUridine
Pharmaceutical intermediate for oligonucleotide synthesis
1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
Pharmaceutical intermediate for oligonucleotide synthesis
2-Bromo-3-fluoro-6-(trifluoromethyl)pyridine
Pharmaceutical intermediate
(1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate
pharmaceutical intermediate for synthesis
N'-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-tetrahydrofuran-2-yl]purin-6-yl]-N,N-dimethyl-acetamidine
Nucleoside phosphoramidite building block
N-[1-[(2S)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropyl]-2-oxopyrimidin-4-yl]acetamide
GJBIWQXFRRQYML-RRUDDRBXSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H](CN1C=CC(=NC1=O)NC(=O)C)COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC
—